CD26/DPP-4: Type 2 Diabetes Drug Target with Potential Influence on Cancer Biology

Kawakita, E; Koya, D; Kanasaki, K

Kanasaki, K (corresponding author), Shimane Univ, Internal Med 1, Fac Med, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.; Kanasaki, K (corresponding author), Kanazawa Med Univ, Med Res Inst, Div Anticipatory Mol Food Sci & Technol, Uchinada, Ishikawa 9200293, Japan.

CANCERS, 2021; 13 (9):

Abstract

Simple Summary Dipeptidyl peptidase (DPP)-4 inhibitor is widely used for type 2 diabetes. Although DPP-4/CD26 has been recognized as both a suppressor......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索